Busulfan (Pharmascience Inc.)
Welcome to the PulseAid listing for the Busulfan drug offered from Pharmascience Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Pharmascience Inc. |
| NON-PROPRIETARY NAME: | busulfan |
| SUBSTANCE NAME: | BUSULFAN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-05-19 |
| END MARKETING DATE: | 0000-00-00 |
Busulfan HUMAN PRESCRIPTION DRUG Details:
| Item Description | Busulfan from Pharmascience Inc. |
| LABELER NAME: | Pharmascience Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 6(mg/mL) |
| START MARKETING DATE: | 2017-05-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51817-170_ac9b6796-6673-4d8a-a743-66f5b868bea5 |
| PRODUCT NDC: | 51817-170 |
| APPLICATION NUMBER: | ANDA207050 |
Other BUSULFAN Pharmaceutical Manufacturers / Labelers:
